TECH - Bio-Techne Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 12.61B
Enterprise value 12.71B
Trailing P/E 53.49
Forward P/E 36.90
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.49
Price/book (mrq)7.40
Enterprise value/revenue 11.31
Enterprise value/EBITDA 32.40

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-10.01%
S&P500 52-week change 32.74%
52-week high 399.33
52-week low 368.00
50-day moving average 379.88
200-day moving average 379.38

Share statistics

Avg vol (3-month) 31.02M
Avg vol (10-day) 3857.61k
Shares outstanding 5157.44M
Implied shares outstanding 6N/A
Float 8155.97M
% held by insiders 10.89%
% held by institutions 196.51%
Shares short (14 May 2023) 43M
Short ratio (14 May 2023) 42.48
Short % of float (14 May 2023) 42.47%
Short % of shares outstanding (14 May 2023) 41.91%
Shares short (prior month 13 Apr 2023) 43.75M

Dividends & splits

Forward annual dividend rate 40.32
Forward annual dividend yield 40.39%
Trailing annual dividend rate 30.32
Trailing annual dividend yield 30.39%
5-year average dividend yield 40.49
Payout ratio 419.08%
Dividend date 325 May 2023
Ex-dividend date 411 May 2023
Last split factor 24:1
Last split date 329 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 24.15%
Operating margin (ttm)24.81%

Management effectiveness

Return on assets (ttm)7.11%
Return on equity (ttm)15.09%

Income statement

Revenue (ttm)1.12B
Revenue per share (ttm)7.16
Quarterly revenue growth (yoy)1.30%
Gross profit (ttm)758.09M
EBITDA 344.29M
Net income avi to common (ttm)271.22M
Diluted EPS (ttm)1.68
Quarterly earnings growth (yoy)15.60%

Balance sheet

Total cash (mrq)157.2M
Total cash per share (mrq)1
Total debt (mrq)473.99M
Total debt/equity (mrq)25.08
Current ratio (mrq)4.05
Book value per share (mrq)12.01

Cash flow statement

Operating cash flow (ttm)273.72M
Levered free cash flow (ttm)225.2M